|
|
|||
![]() |
|||
REVIEW OF MEDICAL MICROBIOLOGYMEDICAL MYCOLOGY
Professor Department of Microbiology & Immunology 23. Flucytosine:
(D) Flucytosine was originally developed as an anti-cancer drug. Its effectiveness is limited to certain yeast form fungi (Cryptococcus neoformans). This drug is usually given orally in combination with parenteral amphotericin B injection. This is because (1) these two drugs work synergistically, and (2) this minimizes the development of drug resistance by susceptible fungi. The drug works as an inhibitor of RNA and DNA synthesis as described in D. (Ryan et al, p. 583 this infection. (Joklik et al, pp. 1117-111; Ryan et al, pp. 614-615)
|
|||
|
|||
|
©1995-2009
Loyola University Chicago Stritch School of Medicine.
|